201 related articles for article (PubMed ID: 21419755)
1. Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study.
Leiviskä J; Sundvall J; Alfthan G; Jauhiainen M; Salomaa V
Clin Chim Acta; 2011 May; 412(11-12):1146-50. PubMed ID: 21419755
[TBL] [Abstract][Full Text] [Related]
2. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
3. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
[TBL] [Abstract][Full Text] [Related]
4. [Decrease ApoB/ApoA-1 ratio and cardiovascular risk improvement: a tadalafil pleiotropic effect? Preliminary study on healthy volunteers].
Roumeguère T; Zouaoui Boudjeltia K; Hauzeur C; Ramal A; Schulman C; Vanhaeverbeek M; Ducobu J; Wespes E
Prog Urol; 2008 Dec; 18(13):1087-91. PubMed ID: 19041816
[TBL] [Abstract][Full Text] [Related]
5. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
6. Apolipoproteins A-I and B-markers in coronary risk evaluation.
Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
[TBL] [Abstract][Full Text] [Related]
7. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.
Walldius G; Aastveit AH; Jungner I
J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103
[TBL] [Abstract][Full Text] [Related]
8. apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men.
Schmidt C; Fagerberg B; Wikstrand J; Hulthe J
Atherosclerosis; 2006 Nov; 189(1):178-85. PubMed ID: 16384562
[TBL] [Abstract][Full Text] [Related]
9. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.
Lundberg S; Gunnarsson I; Jacobson SH
Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235
[TBL] [Abstract][Full Text] [Related]
10. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
Dirisamer A; Stadler A; Bucek RA; Widhalm K
Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
[TBL] [Abstract][Full Text] [Related]
11. The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.
Belfki H; Ben Ali S; Bougatef S; Ben Ahmed D; Haddad N; Jmal A; Abdennebi M; Ben Romdhane H
Exp Mol Pathol; 2011 Oct; 91(2):622-5. PubMed ID: 21801720
[TBL] [Abstract][Full Text] [Related]
12. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
[TBL] [Abstract][Full Text] [Related]
13. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
Meisinger C; Loewel H; Mraz W; Koenig W
Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
[TBL] [Abstract][Full Text] [Related]
15. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.
Kaneva AM; Potolitsyna NN; Bojko ER; Odland JØ
Dis Markers; 2015; 2015():591454. PubMed ID: 25852220
[TBL] [Abstract][Full Text] [Related]
16. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
Walldius G; Jungner I
J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
[TBL] [Abstract][Full Text] [Related]
17. Moderate physical activity is associated with lower ApoB/ApoA-I ratios independently of other risk factors in healthy, middle-aged men.
Behre C; Bergström G; Schmidt C
Angiology; 2010 Nov; 61(8):775-9. PubMed ID: 20566576
[TBL] [Abstract][Full Text] [Related]
18. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
19. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
Holme I; Høstmark AT; Anderssen SA
J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
[TBL] [Abstract][Full Text] [Related]
20. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]